Psychiatry · Medical Literature
Emotion Regulation Treatment for Alcohol Use Disorder: Results of a Stage II Randomized Clinical Efficacy Trial.
Abstract
Despite strong links between emotion regulation (ER) difficulties and problem drinking, few studies have directly addressed whether interventions that target ER positively impact drinking outcomes. In a prior Stage 1a/1b behavioral therapies development study, we developed an Emotion Regulation Treatment (ERT) for alcohol use disorder (AUD) that included strategies addressing prolonged direct experiencing of emotion, mindfulness, and coping and distress tolerance. Results demonstrated the feasibility and initial efficacy of ERT as a supplement to cognitive behavioral therapy (CBT) for AUD. Based on this initial success, the current study reports on a fully powered stage II randomized clinical efficacy trial to compare CBT plus ERT (CBT + ERT) to CBT plus an active health and lifestyles (HLS) control (CBT + HLS) and explore potential mechanisms of action. Adults (n = 194) with moderate-to-severe AUD were enrolled in 12 week outpatient treatment and randomized to either the CBT + ERT or CBT + HLS treatment condition. Analyses evaluated (1) the impact of treatment condition on percent days abstinent (PDA) and percent heavy drinking days (PHDD) at end of treatment (EOT) and 3, 6, and 12 months posttreatment, and (2) whether change trajectories of negative affect, craving, mindfulness, cognitive reappraisal, or adaptive alcohol coping, assessed daily or weekly during treatment, partially accounted for associations between treatment condition and EOT alcohol outcomes. The CBT + ERT group had greater PDA at all posttreatment follow-ups relative to the CBT + HLS group. There were no group differences in PHDD. Levels of PDA and PHDD did not change across posttreatment follow-ups for either group. The CBT + ERT group exhibited greater adaptive alcohol coping across the first week of treatment, which in turn was associated with higher PDA and lower PHDD at EOT. No other mediation effects were detected. CBT + ERT was associated with greater PDA at EOT relative to CBT + HLS, an association that was partially explained by greater adaptive coping early in treatment.
Clinical relevance
In adults with moderate-to-severe alcohol use disorder (AUD) receiving 12-week outpatient cognitive behavioral therapy (CBT), does the addition of a structured Emotion Regulation Treatment (ERT) — targeting prolonged emotional experiencing, mindfulness, and distress tolerance — improve percent days abstinent compared to CBT supplemented with an active health-and-lifestyles control, and does adaptive coping mediate any observed treatment effect? __SNAPSHOT__ {"studyDesign":"Stage II randomized controlled efficacy trial (two-arm, parallel-group); active comparator-controlled","setting":"Outpatient treatment setting; University at Buffalo Research Institute on Addictions, Buffalo, New York, USA","sampleSize":"n = 194 (CBT + ERT vs. CBT + HLS; per-arm allocation not reported in abstract)","population":"Adults with DSM-defined moderate-to-severe AUD enrolled in 12-week outpatient treatment; prior Stage 1a/1b feasibility work established this population as individuals with significant emotion-regulation difficulties and negative-affect-driven drinking patterns","intervention":"CBT + ERT: standard CBT for AUD supplemented with the Emotion Regulation Treatment, a 12-session structured program incorporating prolonged direct emotional experiencing, mindfulness, and coping/distress tolerance strategies","comparator":"CBT + HLS: the same standard CBT for AUD supplemented with an active Health and Lifestyles control condition (active comparator, not placebo/waitlist)","primaryOutcome":"Percent days abstinent (PDA) assessed through up to 12 months post-treatment; mechanisms of action (specifically adaptive coping) explored as secondary/mediational aims","followUp":"Up to 12 months post-treatment","fundingSource":"Government (NIH/NIAAA): awards R01AA024628 and R01AA024628-05S1"}
Key findings
CBT + ERT was associated with a greater percentage of days abstinent (PDA) up to 12 months post-treatment compared to CBT + HLS. The direction and durability of this effect — persisting to 12 months — represents the primary efficacy signal. The treatment effect on PDA was partially mediated by greater adaptive coping early in treatment, suggesting a plausible mechanism of action. Specific absolute PDA values, between-group mean differences, confidence intervals, p-values, effect sizes, and NNT are not reported in the available abstract; these values should be sought in the full publication before clinical application. No adverse event data or between-group harm comparisons are reported in the abstract. Note: all effect size and inferential statistics labeled above as 'not reported' are absent from the abstract; none have been independently calculated.
Practice implications
This fully powered Stage II RCT provides meaningful efficacy evidence that emotion-regulation-focused psychotherapy, when added to standard CBT, improves abstinence outcomes in adults with moderate-to-severe AUD through at least 12 months post-treatment — a clinically meaningful follow-up horizon for a chronic relapsing disorder. The use of an active comparator (CBT + HLS) rather than treatment-as-usual or waitlist control is a methodological strength, as it requires ERT to demonstrate benefit above and beyond an already-active behavioral intervention. The partial mediation through early adaptive coping provides mechanistic plausibility and may inform sequencing (i.e., targeting coping early in treatment). However, the following were NOT established by this study: superiority on secondary drinking outcomes (e.g., drinks per drinking day, heavy drinking days) or quality-of-life measures (not reported in abstract); generalizability beyond the specific population studied (treatment-seeking adults, likely predominantly from a single academic outpatient site); efficacy in patients with severe psychiatric comorbidity, concurrent substance use disorders, or those not motivated for abstinence-oriented goals. The study builds on a well-developed prior Stage 1a/1b program and is therefore not preliminary, but replication in independent samples and diverse settings is needed before broad dissemination. IMPORTANT CAVEAT: This summary is based solely on the published abstract and a journal-level excerpt; critical inferential statistics (p-values, confidence intervals, effect sizes, absolute PDA differences) have not been verified and must be reviewed in the full article before clinical or policy decisions are made. __LIMITATIONS__ 1. Only an abstract and brief journal summary were available for this review; full results including effect sizes, confidence intervals, p-values, attrition rates, and adverse event profiles could not be verified. 2. Single-site or limited-site academic outpatient setting likely limits generalizability to community treatment programs, primary care, or populations with greater socioeconomic diversity. 3. Blinding: therapist blinding is not feasible in behavioral RCTs; participant blinding to treatment condition is unlikely given the distinct content of ERT vs. HLS, introducing performance and detection bias risk. 4. The active comparator design (CBT + HLS vs. CBT + ERT), while a strength, means both arms received substantial behavioral treatment, which may compress between-group differences and make the significant PDA finding more clinically notable but also more difficult to detect (conservative test). 5. Mediation by 'adaptive coping' is correlational and time-lagged but cannot establish causation from the RCT design alone. 6. Attrition over a 12-month follow-up in an AUD population is typically substantial; the degree to which missing data were handled (e.g., intent-to-treat analysis, multiple imputation) is not confirmed from the abstract. 7. Self-report drinking outcomes (PDA) are subject to social desirability bias; biological verification methods are not reported. 8. Applicability to patients with co-occurring severe psychiatric disorders, opioid/stimulant co-use, or mandated treatment populations is unknown. 9. Long-term durability beyond 12 months is not assessed. __BOTTOM_LINE_CATEGORY__ potentially_practice_informing __BOTTOM_LINE__ In adults with moderate-to-severe AUD receiving outpatient CBT, augmenting standard treatment with a structured Emotion Regulation Treatment (ERT) was associated with significantly greater percent days abstinent through 12 months post-treatment versus an active health-and-lifestyles control, with early gains in adaptive coping as a partial mediator. This is a well-designed Stage II efficacy trial with an active comparator and meaningful follow-up duration, supporting ERT as a promising add-on to CBT for AUD — particularly for patients with negative-affect-driven drinking. Clinicians should review the full publication for effect sizes and confidence intervals before implementing ERT broadly; independent replication in community and diverse settings is needed to confirm generalizability.